Xiaoling Ding

Anesthesiology

102-01 66th Road
Forest Hills, NY 11375

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 5 publications

Novel myeloperoxidase-derived HLA-A2-restricted peptides as therapeutic targets against myeloid leukemia.

Novel myeloperoxidase-derived HLA-A2-restricted peptides as therapeutic targets against myeloid leukemia.

Journal: Cytotherapy

Published: December 11, 2020

A novel TCR-like CAR with specificity for PR1/HLA-A2 effectively targets myeloid leukemia in vitro when expressed in human adult peripheral blood and cord blood T cells.

A novel TCR-like CAR with specificity for PR1/HLA-A2 effectively targets myeloid leukemia in vitro when expressed in human adult peripheral blood and cord blood T cells.

Journal: Cytotherapy

Published: March 29, 2016

Loss of an Igκ gene enhancer in mature B cells results in rapid gene silencing and partial reversible dedifferentiation.

Loss of an Igκ gene enhancer in mature B cells results in rapid gene silencing and partial reversible dedifferentiation.

Journal: Molecular and cellular biology

Published: March 20, 2013

Broad cross-presentation of the hematopoietically derived PR1 antigen on solid tumors leads to susceptibility to PR1-targeted immunotherapy.

Broad cross-presentation of the hematopoietically derived PR1 antigen on solid tumors leads to susceptibility to PR1-targeted immunotherapy.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: October 30, 2012

A new hypersensitive site, HS10, and the enhancers, E3' and Ed, differentially regulate Igκ gene expression.

A new hypersensitive site, HS10, and the enhancers, E3' and Ed, differentially regulate Igκ gene expression.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: February 11, 2012

Showing 1-5 of 5

Last Updated: 09/26/2026